Iovance Biotherapeutics(IOVA) - 2023 Q4 - Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Conference Call February 28, 2024 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President, Investor Relations & Corporate Communications Fred Vogt - Interim President & Chief Executive Officer Jim Ziegler - Executive Vice President, Commercial Igor Bilinsky - Chief Operating Officer Friedrich Finckenstein - Chief Medical Officer Jean-Marc Bellemin - Chief Financial Officer Raj Puri - Executive Vice President, Regulatory Strategy & ...